Skip to main content
. 2016 Dec;6(4):498–507. doi: 10.1086/688489

Figure 1.

Figure 1

Flow chart of patients included in the study. A total of 8.3% of patients were excluded due to hepatopulmonary syndrome (HPS), and 5% of patients were excluded due to alternative etiologies of pulmonary arterial hypertension (PAH). Thirty-one controls and 21 case patients with portopulmonary hypertension (POPH) were included in the final cohort.